| |
| Considering outsourcing development and manufacturing? The Outsourced Pharma Capacity Update (OPCU), a free, interactive, digital event, convenes the industry's foremost CDMOs to provide up-to-date and direct insights into their available capacity and services, alongside specific facility and equipment updates. Discover the July 2025 event’s presenting sponsors in this newsletter to learn how they are best suited to help you to navigate the path to approval and commercialization. |
|
| | Viralgen | As a leading CDMO in AAV manufacturing, Viralgen facilitates rapid transition to cGMP with a proven platform and an impeccable 100% IND success rate. Discover how Viralgen drives industry progress. | Request Information | Viralgen |
|
| Minaris Advanced Therapies | With a robust track record of more than 7,500 GMP batches and proven platforms for multiple modalities, Minaris delivers speed, scalability, and reliability to help developers bring cures to patients faster. | Request Information | Minaris Advanced Therapies |
|
| Andelyn Biosciences | Andelyn Biosciences has used its Curator™ adherent platform to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years and covering a variety of serotypes and indications. | Request Information | Andelyn Biosciences |
|
| Excellos | Excellos leverages its extensive starting material expertise as a key differentiator. Deep understanding of partner-sourced raw materials, quality control, and supply chain management creates significant value. | Request Information | Excellos |
|
| | |
|
|
